Literature DB >> 26455587

Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population.

J L Dixon1,2, L A Copeland3,4, J E Zeber3,4, A A MacCarthy5, S I Reznik1,2, W R Smythe1,2, P A Rascoe6,7.   

Abstract

In the past 30 years, the incidence of esophageal adenocarcinoma (EAC) has increased more rapidly than any other cancer in the United States. The prevalence of obesity and diabetes mellitus has drastically increased as well. We explored the potential association between obesity, diabetes mellitus, and EAC. By means of retrospective interrogation of an administrative database from fiscal year 2005-2009, we identified two cohorts. The cancer cohort was defined as patients with adenocarcinoma of the distal esophagus or gastric cardia. The comparison cohort contained patients with gastroesophageal reflux disorder (GERD; diagnosis coupled with a procedure code for fundoplication). Patient data, including demographic measures, diagnoses of obesity, diabetes mellitus, dyslipidemia, alcohol abuse, and nicotine dependence were examined. A logistic regression model identified risk factors for development of EAC. The sample included 2,836 patients identified as having either EAC (1,704) or fundoplication with GERD (1,132). Although slightly higher percentages of the benign cohort were obese, the cancer cohort had more diabetics (30.8% vs. 14.8%; chi-square = 94.5; P < 0.0001). In a logistic regression analysis adjusting for comorbidity and lifestyle factors, diagnosis of diabetes mellitus was significantly associated with esophageal cancer as opposed to GERD without cancer (OR = 2.2; 95% confidence interval [CI] 1.7-2.8). Nicotine dependence was also identified as a risk factor (OR = 1.7; 95% CI 1.4-2.0). We identified a potential association between diabetes mellitus and adenocarcinoma of the esophagus or gastric cardia. This association appears to be independent of obesity. Additionally, nicotine dependence was identified as a risk factor for EAC.
© 2015 International Society for Diseases of the Esophagus.

Entities:  

Keywords:  adenocarcinoma; diabetes; epidemiology; esophageal cancer

Mesh:

Year:  2015        PMID: 26455587     DOI: 10.1111/dote.12402

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  8 in total

Review 1.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

Review 2.  KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Semin Cancer Biol       Date:  2017-10-24       Impact factor: 15.707

3.  4-Nitroquinoline 1-Oxide-Induced Tongue and Esophagus Carcinogenesis in Obese and Diabetic TSOD Mice.

Authors:  Takuji Tanaka; Kunihiro Kawabata; Shigeyuki Sugie
Journal:  World J Oncol       Date:  2017-08-27

Review 4.  Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies.

Authors:  Zhi-Feng Miao; Hao Xu; Ying-Ying Xu; Zhen-Ning Wang; Ting-Ting Zhao; Yong-Xi Song; Hui-Mian Xu
Journal:  Oncotarget       Date:  2017-07-04

Review 5.  Diabetes mellitus carries a risk of esophageal cancer: A meta-analysis.

Authors:  Bo Xu; Xiufang Zhou; Xiaohong Li; Chaoyang Liu; Caizhe Yang
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

6.  Glycemic control and survival of patients with coexisting diabetes mellitus and gastric or esophageal cancer.

Authors:  Nina J Karlin; Matthew R Buras; Heidi E Kosiorek; Patricia M Verona; Curtiss B Cook
Journal:  Future Sci OA       Date:  2019-06-26

7.  Risk of gastrointestinal cancer in patients with an elevated level of gamma-glutamyltransferase: A nationwide population-based study.

Authors:  Seung Wook Hong; Hyun Jung Lee; Kyungdo Han; Jung Min Moon; Seona Park; Hosim Soh; Eun Ae Kang; Jaeyoung Chun; Jong Pil Im; Joo Sung Kim
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

8.  Esophageal Adenocarcinoma: Opportunities for Targeted Prevention in Ohio.

Authors:  Julie A Stephens; James L Fisher; Jessica L Krok-Schoen; Ryan D Baltic; Holly L Sobotka; Electra D Paskett
Journal:  Clin Med Insights Gastroenterol       Date:  2018-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.